Top Authors

• Most frequent coverage on GTXI

• 
  Mike Havrilla (1959 followers)

  • October FDA Calendar Stocks: Tricks or Treats? (Fri, Oct 16)
  • FDA Calendar: 2H09 Binary Event Trades (Mon, Jul 27)
  • Access Pharma: Deep Pipeline, Shallow Valuation (Wed, Jul 15)

  More by Mike Havrilla on GTXI »
• 
  Alan Brochstein (713 followers)

  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)

  More by Alan Brochstein on GTXI »
• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)

  More by Justin M. Hall on GTXI »

• Most followed authors on GTXI

• 
  Mike Havrilla (1959 followers)

  • October FDA Calendar Stocks: Tricks or Treats? (Fri, Oct 16)
  • FDA Calendar: 2H09 Binary Event Trades (Mon, Jul 27)
  • Access Pharma: Deep Pipeline, Shallow Valuation (Wed, Jul 15)

  More by Mike Havrilla on GTXI »
• 
  Andrew Wilkinson (1176 followers)

  • Tuesday Options Outlook: CSCO, KG, IWO, HNT, SIRO, MGM, IWD, GTXI (Tue, Aug 5)
  • Tuesday Options Update: MRK, SNDK, TXN, TAP, GTXI, SPF, BRCD, XLF (Tue, Jul 22)
  • Monday's Options Report: ABK, XLF, WB, GTXI, QCOM, NTAP, DNA, TTWO (Mon, Feb 25)

  More by Andrew Wilkinson on GTXI »
• 
  SA Editor Eli Hoffmann (1057 followers)

  • Wall Street Breakfast: Must-Know News (Mon, Nov 9)

  More by SA Editor Eli Hoffmann on GTXI »

• Newest authors on GTXI

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)

  More by Justin M. Hall on GTXI »
• 
  M. E. Garza (557 followers)

  • Monday's Rx-Recap (11-02-09) (Tue, Nov 3)

  More by M. E. Garza on GTXI »
• 
  The Burrill Report (209 followers)

  • This Week's Failed Trials, Missed Targets in Biotech (Sun, Dec 20)

  More by The Burrill Report on GTXI »

• Most commented on GTXI

• 
  Justin M. Hall (672 followers)

  • Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers (Sun, Sep 20)
  • Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up (Fri, Sep 11)
  • 'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers (Tue, Aug 25)

  More by Justin M. Hall on GTXI »
• 
  SA Editor Eli Hoffmann (1057 followers)

  • Wall Street Breakfast: Must-Know News (Mon, Nov 9)

  More by SA Editor Eli Hoffmann on GTXI »
• 
  Alan Brochstein (713 followers)

  • Cancer Stocks: Lagging Again (Mon, Jul 16)
  • Cancer Stocks Hammered Once Again (Tue, Jun 26)
  • Cancer Stocks Slide Again (Mon, Jun 18)

  More by Alan Brochstein on GTXI »